UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor

American journal of veterinary research, 2011-12, Vol.72 (12), p.1631-1638

2011

Link zum Volltext

Verfügbarkeit prüfen

Systemic Administration of an Attenuated, Tumor-Targeting Salmonella typhimurium to Dogs with Spontaneous Neoplasia: Phase I Evaluation

Clinical cancer research, 2005-07, Vol.11 (13), p.4827-4834

2005

Link zum Volltext

Verfügbarkeit prüfen

Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin's Lymphoma

Clinical cancer research, 2009-05, Vol.15 (10), p.3503-3510

2009

Link zum Volltext

Verfügbarkeit prüfen

IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma

Journal of cellular biochemistry, 2004-05, Vol.92 (1), p.77-91

2004

Link zum Volltext

Verfügbarkeit prüfen

Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs

Veterinary immunology and immunopathology, 2024-01, Vol.267, p.110691-110691, Article 110691

2024

Link zum Volltext

Verfügbarkeit prüfen

Liposome-Encapsulated Doxorubicin (Doxil) and Doxorubicin in the Treatment of Vaccine-Associated Sarcoma in Cats

Journal of veterinary internal medicine, 2002-11, Vol.16 (6), p.726-731

2002

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin and Doxorubicin Combination Chemotherapy for the Treatment of Canine Osteosarcoma: A Pilot Study

Journal of veterinary internal medicine, 2000-09, Vol.14 (5), p.495-498

2000

Link zum Volltext

Verfügbarkeit prüfen

Plasma synthesis of carbon magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery

Journal of biomaterials science. Polymer ed., 2004-01, Vol.15 (8), p.1033-1049

2004

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Investigation of PEGylated Tumor Necrosis Factor α in Dogs with Spontaneous Tumors: Phase I Evaluation

Clinical cancer research, 2010-03, Vol.16 (5), p.1498-1508

2010

Link zum Volltext

Verfügbarkeit prüfen

GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma

BMC veterinary research, 2014-01, Vol.10, p.30-30

2014

Link zum Volltext

Verfügbarkeit prüfen

GS-9219/VDC-1101 - a prodrug of the acyclic nucleotide PMEG has antitumor activity inspontaneous canine multiple myeloma

BMC veterinary research, 2014-01, Vol.10 (1), p.30-30

2014

Link zum Volltext

Verfügbarkeit prüfen

Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma

Veterinary medicine and science, 2017-08, Vol.3 (3), p.134-145

2017

Link zum Volltext

Verfügbarkeit prüfen

STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial

Cancer chemotherapy and pharmacology, 2002-08, Vol.50 (2), p.131-136

2002

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Therapy for Melanoma in Dogs: Results of Randomized Clinical Trials Using Surgery, Liposome-encapsulated Muramyl Tripeptide, and Granulocyte Macrophage Colony-stimulating Factor

Clinical cancer research, 1999-12, Vol.5 (12), p.4249-4258

1999

Link zum Volltext

Verfügbarkeit prüfen

RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target

Melanoma research, 2010-02, Vol.20 (1), p.35-42

2010

Link zum Volltext

Verfügbarkeit prüfen

Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma

Cancer chemotherapy and pharmacology, 2004-07, Vol.54 (1), p.25-33

2004

Link zum Volltext

Verfügbarkeit prüfen

Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model

Clinical cancer research, 1999-09, Vol.5 (9), p.2653-2659

1999

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors for treatment of malignant lymphoma in dogs

Journal of the American Veterinary Medical Association, 1994-12, Vol.205 (12), p.1722

1994

Link zum Volltext

Verfügbarkeit prüfen

Preclinical evaluation of a liposome-encapsulated formulation of cisplatin in clinically normal dogs

American journal of veterinary research, 2004-11, Vol.65 (11), p.1474-1478

2004

Link zum Volltext

Verfügbarkeit prüfen

Amputation and Carboplatin for Treatment of Dogs With Osteosarcoma: 48 Cases (1991 to 1993)

Journal of veterinary internal medicine, 1996-03, Vol.10 (2), p.76-81

1996

Link zum Volltext

Verfügbarkeit prüfen

Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors

Cancer Immunology, Immunotherapy, 2003-08, Vol.52 (8), p.473-480

2003

Link zum Volltext

Verfügbarkeit prüfen

Does l-Asparaginase Influence Efficacy or Toxicity When Added to a Standard CHOP Protocol for Dogs with Lymphoma?

Journal of veterinary internal medicine, 2005-09, Vol.19 (5), p.732-736

2005

Link zum Volltext

Verfügbarkeit prüfen

Obesity in the Dog: Role of the Adrenal Steroid Dehydroepiandrosterone (DHEA)

The Journal of nutrition, 1991-11, Vol.121 (11), p.S51-S55

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Animals
(42)
Dogs
(39)
Science & Technology
(39)
Life Sciences & Biomedicine
(36)
Female
(22)
Male
(22)
Oncology
(20)
Biological And Medical Sciences
(18)
Dog Diseases - Drug Therapy
(17)
Medical Sciences
(17)
Antineoplastic Agents
(14)
Pharmacology. Drug Treatments
(14)
Veterinary Sciences
(14)
Liposomes
(11)
Acetylmuramyl-Alanyl-Isoglutamine - Analogs & Derivatives
(10)
Antineoplastic Agents - Therapeutic Use
(10)
Immunotherapy
(10)
Chemotherapy
(9)
Combined Modality Therapy
(9)
Dog Diseases - Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor

Systemic Administration of an Attenuated, Tumor-Targeting Salmonella typhimurium to Dogs with Spontaneous Neoplasia: Phase I Evaluation

Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin's Lymphoma

IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma

Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs

Liposome-Encapsulated Doxorubicin (Doxil) and Doxorubicin in the Treatment of Vaccine-Associated Sarcoma in Cats

Cisplatin and Doxorubicin Combination Chemotherapy for the Treatment of Canine Osteosarcoma: A Pilot Study

Plasma synthesis of carbon magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery

Preclinical Investigation of PEGylated Tumor Necrosis Factor α in Dogs with Spontaneous Tumors: Phase I Evaluation

GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma

GS-9219/VDC-1101 - a prodrug of the acyclic nucleotide PMEG has antitumor activity inspontaneous canine multiple myeloma

Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma

STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial

Adjuvant Therapy for Melanoma in Dogs: Results of Randomized Clinical Trials Using Surgery, Liposome-encapsulated Muramyl Tripeptide, and Granulocyte Macrophage Colony-stimulating Factor

RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target

Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma

Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model

Prognostic factors for treatment of malignant lymphoma in dogs

Preclinical evaluation of a liposome-encapsulated formulation of cisplatin in clinically normal dogs

Amputation and Carboplatin for Treatment of Dogs With Osteosarcoma: 48 Cases (1991 to 1993)

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative

Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors

Does l-Asparaginase Influence Efficacy or Toxicity When Added to a Standard CHOP Protocol for Dogs with Lymphoma?

Obesity in the Dog: Role of the Adrenal Steroid Dehydroepiandrosterone (DHEA)

Suchergebnisse filtern